1
|
Tummanapalli S, Gulipalli KC, Bodige S, Pommidi AK, Boya R, Choppadandi S, Bakangari MR, Punna SK, Medaboina S, Mamindla DY, Kanuka A, Endoori S, Ganapathi VK, Kottam SD, Kalbhor D, Valluri M. Cu-Catalyzed Tandem C-N and C-C Bond Formation Leading to 4( 1H)-Quinolones: A Scaffold with Diverse Biological Properties from Totally New Raw Materials in a Single Step. J Org Chem 2024; 89:1609-1617. [PMID: 38238153 DOI: 10.1021/acs.joc.3c02215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2024]
Abstract
A novel Cu-catalyzed tandem C-N and C-C bond-formation reaction has been developed to furnish 2-substituted-4-(1H)-quinolones. 4-(1H)-quinolones play an important role in medicinal chemistry. Many 2-aryl(alkyl)-4(1H)-quinolones are found to exhibit diverse biological properties. While traditional methods have inherent issues [like starting materials with incompatible functional groups (NH2 and keto groups)], many modern methods either require activated starting materials (like Ynones) or employ expensive metals (Pd, Rh, Au, etc.) involving carbonylation using CO or metal complexes. Our protocol presents an environmentally friendly one-step method for the construction of these useful 2-substituted-4-(1H)-quinolones from easily available aryl boronic acid (or pinacolate ester) and nitriles as new raw materials, using a cheap Cu-catalyst and O2 (air) as a green oxidant. We further extended its application to the synthesis of various natural products, including the first formal total synthesis of punarnavine. A plausible mechanism involving an aryl nitrilium ion (formed due to the intermolecular C-N bond-forming coupling between aryl boron species and the nitrile group) followed by tandem intramolecular C-C bond formation has been proposed.
Collapse
Affiliation(s)
- Satyanarayana Tummanapalli
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Kali Charan Gulipalli
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Srinu Bodige
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Anil Kumar Pommidi
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Ravi Boya
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Suresh Choppadandi
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Mahendar Reddy Bakangari
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Shiva Kumar Punna
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Srinivas Medaboina
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Devender Yadav Mamindla
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Ashok Kanuka
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Srinivas Endoori
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Vijay Kumar Ganapathi
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Sainath Dharmavaram Kottam
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Dinesh Kalbhor
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| | - Muralikrishna Valluri
- Curia India Pvt. Ltd (Formerly Albany Molecular Research Hyderabad Research Centre), Plot # 9, MN Park, Turkapally, Shameerpet, Genome Valley, RR District, Hyderabad 500078, India
| |
Collapse
|
2
|
Dine I, Mulugeta E, Melaku Y, Belete M. Recent advances in the synthesis of pharmaceutically active 4-quinolone and its analogues: a review. RSC Adv 2023; 13:8657-8682. [PMID: 36936849 PMCID: PMC10015437 DOI: 10.1039/d3ra00749a] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Accepted: 03/01/2023] [Indexed: 03/17/2023] Open
Abstract
4-Quinolone and its analogs are heterocyclic classes of organic compounds displaying biologically active and a broad spectrum of pharmaceutical drug scaffolds. 4-Quinolone is the first-line chemotherapeutic treatment for a wide spectrum of bacterial infections. Recently, 4-quinolone and its derivatives have been shown to have the potential to cure and regulate various acute and chronic diseases, including pain, ischemia, immunomodulation, inflammation, malarial, bacterial infection, fungal infection, HIV, and cancer, based on several reports. This review highlights and provides brief information to better understand the development of experimental progress made to date in the synthetic protocol towards 4-quinolone and its analogs. Thus, classical synthesis protocol, metal-free reaction protocol, and transition metal-catalyzed reaction procedures are briefly discussed along with the pharmaceutical activities of selected 4-quinolone derivatives.
Collapse
Affiliation(s)
- Ilili Dine
- Department of Applied Chemistry, School of Applied Natural Science, Adama Science and Technology University P.O. Box 1888 Adama Ethiopia
| | - Endale Mulugeta
- Department of Applied Chemistry, School of Applied Natural Science, Adama Science and Technology University P.O. Box 1888 Adama Ethiopia
| | - Yadessa Melaku
- Department of Applied Chemistry, School of Applied Natural Science, Adama Science and Technology University P.O. Box 1888 Adama Ethiopia
| | - Melis Belete
- Department of Applied Chemistry, School of Applied Natural Science, Adama Science and Technology University P.O. Box 1888 Adama Ethiopia
| |
Collapse
|
3
|
Silva VLM, Pinto DCGA, Santos CMM, Rocha DHA. 15.4.5 Quinolinones and Related Systems (Update 2022). KNOWLEDGE UPDATES 2022/3 2022. [DOI: 10.1055/sos-sd-115-01218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2025]
Abstract
AbstractQuinolinones, of which the quinolin-4(1H)-one ring system can be highlighted, represent an exciting class of nitrogen heterocycles. The quinolinone motif can be found in many natural compounds and approved drugs for several diseases. This chapter is a comprehensive survey of the methods for the synthesis of quinolin-2(1H)-ones, quinolin-4(1H)-ones, and their thio- and amino derivatives, and is an update to the previous Science of Synthesis chapter (Section 15.4), covering the period between 2003 and 2020.
Collapse
|
6
|
Recent advances in the synthetic and medicinal perspective of quinolones: A review. Bioorg Chem 2019; 92:103291. [PMID: 31561107 DOI: 10.1016/j.bioorg.2019.103291] [Citation(s) in RCA: 83] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2019] [Revised: 09/12/2019] [Accepted: 09/16/2019] [Indexed: 12/16/2022]
Abstract
In the modern scenario, the quinolone scaffold has emerged as a very potent motif considering its clinical significance. Quinolones possess wide range of pharmacological activities such as anticancer, antibacterial, antifungal, antiprotozoal, antiviral, anti-inflammatory, carbonic anhydrase inhibitory and diuretic activity etc. The versatile synthetic approaches have been successfully applied and several of the resulted synthesized compounds exhibit fascinating biological activities in numerous fields. This has prompted to discover quinolone-based analogues among the researchers due to its great diversity in biological activities. In the past few years, various new, efficient and convenient synthetic approaches (including green chemistry and microwave-assisted synthesis) have been designed and developed to synthesize diverse quinolone-based scaffolds which represent a growing area of interest in academic and industry as well as to explore their biological activities. In this review, an attempt has been made by the authors to summarize (1) One of the most comprehensive listings of quinolone-based drugs or agents in the market or under various stages of clinical development; (2) Recent advances in the synthetic strategies for quinolone derivatives as well as their biological implications including insight of mechanistic studies. (3) Further, the biological data is correlated with structure-activity relationship studies to provide an insight into the rational design of more active agents.
Collapse
|
9
|
Hasan P, Pillalamarri VK, Aneja B, Irfan M, Azam M, Perwez A, Maguire R, Yadava U, Kavanagh K, Daniliuc CG, Ahmad MB, Rizvi MMA, Rizwanul Haq QM, Addlagatta A, Abid M. Synthesis and mechanistic studies of diketo acids and their bioisosteres as potential antibacterial agents. Eur J Med Chem 2018; 163:67-82. [PMID: 30503944 DOI: 10.1016/j.ejmech.2018.11.053] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2018] [Revised: 10/13/2018] [Accepted: 11/21/2018] [Indexed: 11/16/2022]
Abstract
A series of diketo esters and their pertinent bioisosteres were designed and synthesized as potent antibacterial agents by targeting methionine amino peptidases (MetAPs). In the biochemical assay against purified MetAPs from Streptococcus pneumoniae (SpMetAP1a), Mycobacterium tuberculosis (MtMetAP1c), Enterococcus faecalis (EfMetAP1a) and human (HsMetAP1b), compounds 3a, 4a and 5a showed more than 85% inhibition of all the tested MetAPs at 100 μM concentration. Compounds 4a and 5a also exhibited antibacterial potential with MIC values 62.5 μg/mL (S. pneumoniae), 31.25 μg/mL (E. faecalis), 62.5 μg/mL (Escherichia coli) and 62.5 μg/mL (S. pneumoniae), 62.5 μg/mL (E. coli), respectively. Moreover, 5a also significantly inhibited the growth of multidrug resistant E. coli strains at 512 μg/mL conc., while showing no cytotoxic effect towards healthy CHO cells and thus being selected. Growth kinetics study showed significant inhibition of bacterial growth when treated with different conc. of 5a. TEM analysis also displayed vital damage to bacterial cells by 5a at MIC conc. Moreover, significant inhibition of biofilm formation was observed in bacterial cells treated with MIC conc. of 5a as visualized by SEM micrographs. Interestingly, 5a did not cause an alteration in the hemocyte density in Galleria mellonella larvae which is considered in vivo model for antimicrobial studies and was non-toxic up to a conc. of 2.5 mg/mL.
Collapse
Affiliation(s)
- Phool Hasan
- Medicinal Chemistry Laboratory, Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India; Department of Chemistry, TNB College, TM Bhagalpur University, Bhagalpur, 812007, India
| | - Vijay K Pillalamarri
- Centre for Chemical Biology, Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500607, India
| | - Babita Aneja
- Medicinal Chemistry Laboratory, Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India
| | - Mohammad Irfan
- Medicinal Chemistry Laboratory, Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India
| | - Mudsser Azam
- Microbiology Research Laboratory, Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India
| | - Ahmad Perwez
- Genome Biology Laboratory, Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India
| | - Ronan Maguire
- Department of Biology, Maynooth University, Co. Kildare, W23 F2H6, Ireland
| | - Umesh Yadava
- Department of Physics, Deen Dayal Upadhyay Gorakhpur University, Gorakhpur, Uttar Pradesh, 273009, India
| | - Kevin Kavanagh
- Department of Biology, Maynooth University, Co. Kildare, W23 F2H6, Ireland
| | | | - Md Belal Ahmad
- Department of Chemistry, TNB College, TM Bhagalpur University, Bhagalpur, 812007, India
| | - M Moshahid A Rizvi
- Genome Biology Laboratory, Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India
| | - Qazi Mohd Rizwanul Haq
- Microbiology Research Laboratory, Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India
| | - Anthony Addlagatta
- Centre for Chemical Biology, Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500607, India
| | - Mohammad Abid
- Medicinal Chemistry Laboratory, Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India.
| |
Collapse
|
10
|
Aneja B, Arif R, Perwez A, Napoleon JV, Hasan P, Rizvi MMA, Azam A, Rahisuddin, Abid M. N-Substituted 1,2,3-Triazolyl-Appended Indole-Chalcone Hybrids as Potential DNA Intercalators Endowed with Antioxidant and Anticancer Properties. ChemistrySelect 2018. [DOI: 10.1002/slct.201702913] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Babita Aneja
- Department of Biosciences; Jamia Millia Islamia; Medicinal Chemistry Laboratory, Jamia Nagar; New Delhi 110025 India
- Department of Chemistry; Jamia Millia Islamia, Jamia Nagar; New Delhi 110025 India
| | - Rizwan Arif
- Department of Chemistry; Jamia Millia Islamia, Jamia Nagar; New Delhi 110025 India
| | - Ahmad Perwez
- Department of Biosciences; Jamia Millia Islamia; Genome Biology Laboratory, Jamia Nagar; New Delhi 110025 India
| | - John V. Napoleon
- Eppley Institute for Research in Cancer and Allied Diseases; University of Nebraska Medical Center; Omaha, NE 68198-6805 USA
| | - Phool Hasan
- Department of Biosciences; Jamia Millia Islamia; Medicinal Chemistry Laboratory, Jamia Nagar; New Delhi 110025 India
| | - M. Moshahid A. Rizvi
- Department of Biosciences; Jamia Millia Islamia; Genome Biology Laboratory, Jamia Nagar; New Delhi 110025 India
| | - Amir Azam
- Department of Chemistry; Jamia Millia Islamia, Jamia Nagar; New Delhi 110025 India
| | - Rahisuddin
- Department of Chemistry; Jamia Millia Islamia, Jamia Nagar; New Delhi 110025 India
| | - Mohammad Abid
- Department of Biosciences; Jamia Millia Islamia; Medicinal Chemistry Laboratory, Jamia Nagar; New Delhi 110025 India
| |
Collapse
|